Type 1 Invariant Natural Killer T Cells Drive Lung Fibrosis
Emily Calamita(Imperial College London), Adam J. Byrne(Imperial College London), Cormac McCarthy(Trinity College Dublin), W. Hertz, Leia R. Griffin(Imperial College London), Albert Agro, Toby M. Maher(University of Southern California), Philip L. Molyneaux(Guy's and St Thomas' NHS Foundation Trust), Wing Han Liu(Queen Mary Hospital), Vipin Kumar(Torrey Pines Institute For Molecular Studies), Clare M. Lloyd(Imperial College London), Christina Michalaki(Lung Institute), Julie C. Worrell(University College Dublin), Faye Murphy(University College Dublin), Patricia P. Ogger(Imperial College London)
Cited by 5
Related Papers
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4 <b>+</b> CD25 <b>+</b> regulatory T cells is interleukin 10 dependent
|The Journal of Experimental Medicine|2005|515
Pulmonary fibrosis secondary to COVID-19: a call to arms?
|The Lancet Respiratory Medicine|2020|498
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
|The Lancet Respiratory Medicine|2017|299
IL-9 Governs Allergen-induced Mast Cell Numbers in the Lung and Chronic Remodeling of the Airways
|American Journal of Respiratory and Critical Care Medicine|2010|211